Fig. 1 · Structure
Documents & Downloads
Bischloroanthrabenzoxocinone
FASII Inhibitor
Bischloroanthrabenzoxocinone is a potent inhibitor of Type II fatty acid synthesis (FASII). This compound effectively disrupts fatty acid synthesis and exhibits significant antibacterial activity. It also inhibits critical processes such as phospholipid, DNA, RNA, protein, and cell wall synthesis, making it a valuable tool for research in microbiology and antibiotic development.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 866022-28-8 |
| Applications | FASII Inhibitor |
| Formula | C28H24Cl2O7 |
| Molecular Weight | 543.39 |
| Synonyms | (-)-BABX |
| SMILES | OC1=C(C(C2)=CC(C(C)(C3=C4Cl)C)=C1C(C3=C(C(Cl)=C4O)O)=O)[C@](O[C@@]25C)([H])C(C(O5)=CC(OC)=C6)=C6C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.